Corcept Therapeutics (CORT) EBIT Margin (2012 - 2026)
Corcept Therapeutics' EBIT Margin was 33.70% in Q3 2026, up 28.77 percentage points from 4.92% a year earlier and up 17.57 percentage points from the prior quarter.
Powered by 
Analysis
Corcept Therapeutics (CORT) EBIT Margin (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Corcept Therapeutics' EBIT Margin was 11.51% through Sep 30, 2026, up 2.66 percentage points year-over-year; for FY2025, it came in at 5.88%, down 14.40 percentage points from FY2024.
- EBIT Margin has now declined for six consecutive years, with a five-year change of -30.34 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was 20.29% in FY2024 (-1.95 pp), 22.24% in FY2023 (-5.79 pp), 28.03% in FY2022 (-5.98 pp) and 34.01% in FY2021 (-2.22 pp).
- The Q3 2026 figure marks the highest quarterly EBIT Margin since Q4 2021.
- Compared with a year earlier, EBIT Margin was higher in two of the last eight quarters, with an average year-over-year change of -8.60 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q3 2026 (a gain of 28.77 percentage points); the worst was Q1 2026 (a drop of 32.25 percentage points).
- Per Business Quant data, CORT's EBIT Margin in the three quarters before Q3 2026 was 16.12% (Q2 2026), -30.08% (Q1 2026) and 2.22% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 32.98% |
| 10 | Corcept Therapeutics | 7.99 Bn | 6.60 Bn | 335.86 Mn | 33.70% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 33.70% |
| Jun 30, 2026 | 16.12% |
| Mar 31, 2026 | -30.08% |
| Dec 31, 2025 | 2.22% |
| Sep 30, 2025 | 4.92% |
| Jun 30, 2025 | 13.72% |
| Mar 31, 2025 | 2.17% |
| Dec 31, 2024 | 13.89% |
| Sep 30, 2024 | 25.53% |
| Jun 30, 2024 | 21.73% |
| Mar 31, 2024 | 20.09% |
| Dec 31, 2023 | 23.39% |
| Sep 30, 2023 | 25.22% |
| Jun 30, 2023 | 25.13% |
| Mar 31, 2023 | 14.06% |
| Dec 31, 2022 | 21.83% |
| Sep 30, 2022 | 31.39% |
| Jun 30, 2022 | 30.40% |
| Mar 31, 2022 | 28.57% |
| Dec 31, 2021 | 37.10% |
API Access
Corcept Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();